Surgical biology for the clinician: vascular effects of immunosuppression.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Impact of Exercise Modalities on Peripheral and Central Components of Cardiorespiratory Capacity in Heart Transplantation Patients: A Systematic Review and Meta-Analysis.Medicina (Kaunas, Lithuania) · 2021
   Pooled it
2. Immunosuppression and vascular remodeling after liver transplantation: Mechanisms, surrogate markers, and modifiable pathways.World journal of transplantation · 2026
   Review
3. A Precisely Controlled Long-Acting Immunosuppression Platform Enables Prolonged Survival of Vascularized Composite Allografts.bioRxiv : the preprint server for biology · 2025
   Article
4. Protocol Biopsies Reveal Progressive Arteriolar Thickening as a Predictor of Mortality in Kidney Transplant Recipients.Life (Basel, Switzerland) · 2025
   Article
5. Rapidly Growing and Ruptured Great Saphenous Vein Aneurysm in a Liver Transplant Patient.Medicina (Kaunas, Lithuania) · 2024
   Article
6. Beneficial effects of rapamycin on endothelial function in systemic lupus erythematosus.Frontiers in physiology · 2024
   Article
7. Combined abdominal heterotopic heart and aorta transplant model in mice.PloS one · 2020
   Article
8. Immunosuppressive protocols with tacrolimus after cryopreserved aortal allotransplantation in rats.PloS one · 2018
   Article
9. The clinical characteristics of posterior reversible encephalopathy syndrome in patients with chronic renal failure.Experimental and therapeutic medicine · 2017
   Article
10. Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2015
    Article
11. Graft microvascular disease in solid organ transplantation.Journal of molecular medicine (Berlin, Germany) · 2014
    Review
12. Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients.World journal of transplantation · 2014
    Article
13. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension.BioMed research international · 2014
    Review
14. Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats.PloS one · 2014
    Article
15. Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells.Journal of cellular and molecular medicine · 2012
    Article
16. Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions.Expert opinion on drug metabolism & toxicology · 2011
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

7 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as